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156a Sunday, February 3, 2013(5.5750.03). E99K increased TLC (tension at pCa 8.0: 0.2250.03 THC)
compared to WT (0.1050.02 THC), but A331P maintained similar TLC
(0.0850.01 THC) to WT. Five equilibrium constants of the cross-bridge
cycle were deduced using sinusoidal analysis. E99K caused a decrease in both
K0 (ADP dissociation: 16.654.6 mM
1) and K1 (ATP association:
1.5150.08 mM1) compared to WT (35.0456.3 mM1 and 2.150.3 mM1,
respectively). A331P and WT showed similar K0 (3155.4 mM
1 and
35.0456.3 mM1), K1 (1.650.2 mM
1 and 2.150.3 mM1), K2 (cross-bridge
detachment: 0.6950.1 and 0.7850.13), K4 (force generation: 0.2750.03 and
0.3450.03), and K5 (Pi association: 0.1350.2 mM
1 and 0.1250.01 mM1).
The cross-bridge distributionwas similar amongWT,E99K andA331P, indicat-
ing that force/cross-bridge is decreased in K99K and A331P. In conclusion,
E99K actin causes HCM through impaired relaxation and elevated pCa50
(diastolic problem), and lowered force/cross-bridge (systolic problem), whereas
A331P actin causes HCM through decreased pCa50 and force/cross-bridge
(systolic problem).
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Healthy heart function and structure, from the tissue to cellular scale, depends
on establishment of proper tissue mechanics. On the cellular scale, late embry-
onic, neonatal and adult cardiomyocytes exhibit mechanosensitivity to ECM
elasticity [1], such that culturing on substrates of physiological stiffness of
~10-20 kPa optimizes function. However, the heart begins functioning long be-
fore this mature mechanical environment is established. Here we examine the
effects of microenvironment mechanics on chick cardiomyocyte function dur-
ing early development, embryonic day 2-4 (E2-E4). Micropipette aspiration
measurements give an effective Young’s modulus of ~1-2 kPa at these earliest
stages. Quantitative Mass Spectroscopy of embryonic myocardium identifies
abundant structural proteins that most likely contribute to tissue mechanics.
In particular, collagen I expression parallels the mechanical stiffening of the
heart tissue. Treatment with collagenase or transglutaminase respectively
softens or stiffens heart tissue in a dose dependent manner while maintaining
functional cellular contractile machinery. Both stiffening and softening whole
heart tubes reduces tissue strain during contraction, suggesting an optimumme-
chanics for myocardial contraction even at the earliest functional stages. Con-
traction wave velocity, however, changes proportionally to the stiffness of the
tissue. E3-4 cardiomyocytes cultured on collagen-coated polyacrylamide gel
substrates of different stiffnesses are best able to contract on substrates of
~1.5 kPa, consistent with the physiological stiffness of the tissue from which
they were derived. As in the whole heart, the cells were also less able to con-
tract on much softer substrates of 300 Pa, or stiffer substrates of 10 kPa or more.
This further points to optimizing mechanics for cardiomyocyte strain that
matches the physiological stiffness of myocardium throughout development.
Finally, effects environmental mechanics on nuclear proteins during develop-
ment are being explored.
[1] Majkut SF, Discher DE. (2012). BMMB. Doi: 10.1007/s10237-012-0413-8
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Familial hypertrophic cardiomyopathy (HCM) is frequently caused by muta-
tions in genes encoding sarcomeric proteins. Energy depletion of the heart is
thought to initiate and promote HCM disease development. It has been hypoth-
esized that HCM sarcomere gene mutations increase ATP utilization for myo-
filament contraction and thereby increase energy demand of the heart. Previous
studies in single left ventricular myofibrils from myocardium harbouring the
first identified causal HCM mutation R403Q in the gene encoding b-myosin
heavy chain revealed increased rates of tension generation and relaxation in
R403Q compared to myofibrils from healthy control myocardium. The altered
kinetics observed in the mutant sample predicted a 3-fold increase in the energy
cost of tension generation in R403Q sarcomeres. In the present study we inves-
tigated if tension cost was indeed increased in human myocardium harbouring
the R403Q mutation.
Maximal force generating capacity (Fmax) and ATP consumption (ATPmax)
were simultaneously measured in Triton-permeabilized left ventricular musclestrips (n=8) from a patient carrying the R403Q mutation. Left ventricular mus-
cle strips (n=17) from 5 HCM sarcomere mutation negative patients (HCMsmn)
and strips (n=6) from 2 patients with secondary hypertrophy due to aortic ste-
nosis (LVHao) served as a control groups. Economy of myofilament contraction
is expressed as tension cost (TC), i.e. amount of ATP used during force devel-
opment (ATPmax/Fmax). Both Fmax and ATPmax were significantly lower in
R403Q compared to HCMsmn and LVHao. TC was significantly increased in
R403Q (3.850.5 mmolL1s1/kNm2) compared to HCMsmn and LVHao
(1.650.1 and 1.750.1 mmolL1s-1/kNm2, respectively).
Our data provide direct evidence that TC is increased in myocardium harbour-
ing the MYH7 mutation R403Q, indicating that expression of R403Q in the
heart impairs economy of myocardial contraction.
Funding: Seventh Framework Program of the European Union ‘‘BIG-
HEART,’’ grant agreement 241577
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A cluster of cardiomyopathy mutation sites in b-cardiac myosin including a par-
ticularly lethal mutation of E930del can be targeted to part of the N-terminal
region of myosin subfragment-2. A peptide model of this system was synthe-
sized and labeled with resonance energy transfer probes to detect the stability
of coiled coil formation and estimates of the monomer-dimer equilibrium of the
peptide. Distance measurements between the donor and acceptor probes were
consistent with computational simulations of the labeled peptides in a coiled
coil structure which matched simulations of the unlabeled wildtype structure.
The addition of a site-specific antibody to this peptide strongly inhibited reso-
nance energy transfer, indicating that the coiled coil structure was destabilized.
In contrast, the addition of certain polyamine structures improved the stability
of the coiled coil, while other polyamines had little effect despite having signif-
icant binding constants to myosin as determined by competitive ELISA assays.
The length of the polyamine appears to be important for this ability to stabilize
the coiled coil in this region of negatively charged glutamates in the myosin
subfragment-2 sequence. Some of the polyamines may be capable of binding
both a-helixes of the myosin subfragment-2 simultaneously, thereby stabilizing
the coiled coil structure. This synthetic peptide model system holds promise as
a test system for small molecule compounds that may counteract the destabiliz-
ing effects of some cardiomyopathy mutations on the myosin coiled coil struc-
ture. (sponsored by NSF ARRA)
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Myosin is the chemomechanical energy transducer in striated muscle working
in the heart to circulate blood. Transduction occurs by cyclical actomyosin in-
teraction causing myosin thick filament sliding relative to the actin thin fila-
ment while consuming chemical energy from ATP. Transduction begins in
the myosin head domain or cross-bridge with ATP hydrolysis driving rotary
movement of a lever-arm converting rotation into linear translation. Myosin
regulatory light chain (RLC) binds to the lever-arm and affects its ability to
translate actin. Gene sequencing implicated several RLC mutations in human
heart disease and three of them are investigated here using single molecule
detection of photoactivatable GFP tagged RLC (RLC-PAGFP) exchanged
into permeabilized porcine papillary muscle fibers. The RLC-PAGFP detects
single lever-arm orientation. Single molecule orientation detection benefits
from new analysis tools to deduce PAGFP orientation from the 3 spatial di-
mensional fluorescence emission pattern. Experiments were performed in a mi-
crofluidic chamber designed for isometric contraction, total internal reflection
fluorescence single molecule detection, and for 2-photon excitation second
harmonic generation to evaluate sarcomere length. The RLC-PAGFP reports
discretized lever-arm orientation intermediates in active isometric fibers char-
acteristic to the wild type (WT) RLC where lever-arms occupy intermediates
on the free-energy gradient that on average correspond to the cross-bridge
stall force. Two disease linked mutants introduced to RLC move state occu-
pancy further down the free energy gradient implying lever-arms rotate
more to reach cross-bridge stall force because mutant RLC increases lever-
arm shear strain. Lower free energy states could involve strong binding that
will inhibit filament sliding in contraction. This research was supported by
NIH Institutes: NIAMS R01 AR049277 and NHLBI HL095572 and by the
Mayo Foundation.
